These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 15360012)
1. Somatostatin receptor scintigraphy in MALT lymphoma of the lacrimal gland treated with rituximab. Morgensztern D; Rosado MF; Serafini AN; Lossos IS Leuk Lymphoma; 2004 Jun; 45(6):1275-8. PubMed ID: 15360012 [TBL] [Abstract][Full Text] [Related]
2. Somatostatin-receptor scintigraphy for staging and follow-up of patients with extraintestinal marginal zone B-cell lymphoma of the mucosa associated lymphoid tissue (MALT)-type. Raderer M; Traub T; Formanek M; Virgolini I; Osterreicher C; Fiebiger W; Penz M; Jäger U; Pont J; Chott A; Kurtaran A Br J Cancer; 2001 Nov; 85(10):1462-6. PubMed ID: 11720429 [TBL] [Abstract][Full Text] [Related]
3. Can Interim 18F-FDG PET or Diffusion-Weighted MRI Predict End-of-Treatment Outcome in FDG-Avid MALT Lymphoma After Rituximab-Based Therapy?: A Preliminary Study in 15 Patients. Mayerhoefer ME; Karanikas G; Kletter K; Kiesewetter B; Weber M; Rausch I; Pones M; Simonitsch-Klupp I; Müllauer L; Dolak W; Lukas J; Raderer M Clin Nucl Med; 2016 Nov; 41(11):837-843. PubMed ID: 27648705 [TBL] [Abstract][Full Text] [Related]
4. Rituximab for the treatment of extranodal marginal zone B-cell lymphoma of the lacrimal gland. Heinz C; Merz H; Nieschalk M; Mueller-Miny H; Koch P; Heiligenhaus A Br J Ophthalmol; 2007 Nov; 91(11):1563-4. PubMed ID: 17947275 [No Abstract] [Full Text] [Related]
5. MALT lymphoma of the lacrimal gland in the context of systemic lupus erythematosus: complete remission after treatment with rituximab. Tektonidou MG Lupus; 2010 Sep; 19(10):1243-5. PubMed ID: 20501524 [TBL] [Abstract][Full Text] [Related]
6. PET/CT findings in a case with FDG-avid disseminated lacrimal gland MALToma with sequential development of large B-cell lymphoma and gastric MALToma. Yildirim-Poyraz N; Ozdemir E; Basturk A; Kilicarslan A; Turkolmez S Clin Nucl Med; 2015 Feb; 40(2):141-5. PubMed ID: 24873799 [TBL] [Abstract][Full Text] [Related]
7. 111In-DOTA- dPhe1-Tyr3-octreotide, 111In-DOTA-lanreotide and 67Ga citrate scintigraphy for visualisation of extranodal marginal zone B-cell lymphoma of the MALT type: a comparative study. Li S; Kurtaran A; Li M; Traub-Weidinger T; Kienast O; Schima W; Angelberger P; Virgolini I; Raderer M; Dudczak R Eur J Nucl Med Mol Imaging; 2003 Aug; 30(8):1087-95. PubMed ID: 12768334 [TBL] [Abstract][Full Text] [Related]
8. Favourable response to rituximab by an ocular adnexal primary lymphoma. Luque Valentin-Fernandez ML; Alvarez Rodríguez F; Rodríguez Jiménez I Arch Soc Esp Oftalmol; 2016 Nov; 91(11):539-542. PubMed ID: 27125186 [TBL] [Abstract][Full Text] [Related]
9. Systemically disseminated extranodal marginal zone B-cell lymphoma of lacrimal gland in a patient with systemic lupus erythematosus. Lin YC; Kau HC; Kao SC; Hsu WM; Tsai CC Ophthalmic Plast Reconstr Surg; 2007; 23(1):72-3. PubMed ID: 17237702 [TBL] [Abstract][Full Text] [Related]
11. [Case of a bilateral MALT lymphoma of the lacrimal sac treated only medically]. Abdelkhalek R; Ahmimech J; Mouzariae Y; El Idrissi A; El Hamichi S; Messaoudi R; Bargach T; Reda K; Oubaaz A J Fr Ophtalmol; 2015 Dec; 38(10):e237. PubMed ID: 26616299 [No Abstract] [Full Text] [Related]
12. Treatment of localized oral MALT lymphoma by rituximab: a case report. Yamagata K; Onizawa K; Kojima H; Yoshida H Oral Maxillofac Surg; 2008 Dec; 12(4):227-30. PubMed ID: 18830723 [TBL] [Abstract][Full Text] [Related]
13. Rituximab for treatment of advanced extranodal marginal zone B cell lymphoma of the mucosa-associated lymphoid tissue lymphoma. Raderer M; Jäger G; Brugger S; Püspök A; Fiebiger W; Drach J; Wotherspoon A; Chott A Oncology; 2003; 65(4):306-10. PubMed ID: 14707449 [TBL] [Abstract][Full Text] [Related]
14. Multifocal mucosa-associated lymphoid tissue lymphoma associated with IgG4-related disease: a case report. Oyama T; Takizawa J; Nakamura N; Aoki S; Aizawa Y; Abe H Jpn J Ophthalmol; 2011 May; 55(3):304-306. PubMed ID: 21584726 [No Abstract] [Full Text] [Related]
15. Extended rituximab schedules may result in increased efficacy in pulmonary malt lymphoma. Seker M; Bilici A; Ustaalioglu BO; Salman T; Sonmez B; Canpolat NA; Salepci T; Gumus M; Yaylaci M Leuk Res; 2009 Sep; 33(9):e154-6. PubMed ID: 19386361 [No Abstract] [Full Text] [Related]